Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Addict. 2021 Jun 1;30(5):433–444. doi: 10.1111/ajad.13176

Table 2.

Model results of logistic regression including 2-way age by baseline characteristic interaction estimating the odds of relapse. Within each model, the effect of the baseline characteristic on relapse is estimated separately among young adults and among older adults.

Overall Effecta of 2-way Age*Baseline Measure Interaction Effect of baseline measure among young adults (≤25 years) Effect of baseline measure among older adults (>25 years)
Baseline characteristic measure F(df) p-value aORb 95% CI p-value aORb 95% CI p-value
Demographics
Gender (ref=Female) F(1, 558)=0.29 0.592 1.24 (0.54, 2.86) 0.611 0.96 (0.62, 1.48) 0.855
Substance Use
Any current heroin use (ref=No) F(1, 558)=0.54 0.461 2.78 (0.80, 9.63) 0.107 1.66 (0.93, 2.97) 0.084
Any current intravenous use (ref=No) F(1, 558)=0.09 0.765 0.91 (0.34, 2.46) 0.855 1.07 (0.72, 1.60) 0.730
Cigarette smoker (ref=Non-smoker) F(2, 552)=1.40 0.247
 Every day 2.08 (0.27, 15.92) 0.478 0.64 (0.36, 1.14) 0.130
 Some days 3.89 (0.31, 48.10) 0.290 0.41 (0.17, 0.98) 0.046
Any current cocaine/crack use (ref=No) F(1, 558)=0.07 0.786 0.96 (0.41, 2.23) 0.917 0.84 (0.57, 1.24) 0.381
Any current cannabis use (ref=No) F(1, 558)=0.17 0.683 1.06 (0.43, 2.62) 0.899 0.86 (0.59, 1.27) 0.455
Past Treatment History
Current treatment is first treatment in lifetime (ref=No) F(1, 558)=0.11 0.740 1.13 (0.48, 2.65) 0.784 0.96 (0.64, 1.44) 0.848
Past methadone or buprenorphine treatment successful (ref=No) F(1, 558)=0.45 0.504 0.92 (0.35, 2.41) 0.870 1.32 (0.88, 1.97) 0.181
Past naltrexone treatment successful NA*
Opioid Withdrawal
Subjective Opioid Withdrawal Scale (range: 0–64) F(1, 558)=0.13 0.719 1.14 (0.72, 1.80) 0.584 1.04 (0.85, 1.27) 0.718
Other Psychiatric Symptoms/Disorders
Hamilton Depression scale (ref=None) F(2, 555)=0.07 0.929
 Mild 1.19 (0.47, 3.00) 0.713 1.03 (0.66, 1.60) 0.912
 Moderate/Severe 1.34 (0.31, 5.81) 0.694 1.05 (0.55, 1.99) 0.890
Anxiety-depression moderate or extreme (EuroQoL) (ref=None) F(1, 558)=1.99 0.159 1.95 (0.72, 5.29) 0.191 0.90 (0.60, 1.36) 0.620
Suicidal thoughts (ref=No) F(1, 558)=0.37 0.546 0.61 (0.13, 2.98) 0.545 1.07 (0.45, 2.53) 0.879
Social/Living Situation
Current homelessness (ref=No) F(1, 558)=0.32 0.575 1.25 (0.44, 3.58) 0.678 0.90 (0.58, 1.40) 0.642
Any friends/family with heroin/other opioid problems (ref=No) F(1, 553)=0.69 0.407 0.50 (0.18, 1.39) 0.185 0.80 (0.54, 1.18) 0.256
Legal Issues
Current probation/parole (ref=No) F(1, 557)=0.01 0.933 1.68 (0.59, 4.78) 0.327 1.60 (0.91, 2.82) 0.103
Motivation for Participating/
Attitudes Regarding Medication
Participating to avoid relapse NA*
Participating because of family/friends (ref=Disagree) F(2, 555)=1.56 0.212
 Agree 3.34 (0.70, 15.97) 0.131 0.90 (0.51, 1.59) 0.722
 Neutral 0.63 (0.22, 1.81) 0.394 0.90 (0.56, 1.44) 0.651
Prefer to receive BUP-NX (ref=Disagree) F(2, 555)=1.96 0.142
 Agree 1.06 (0.30, 3.66) 0.932 1.27 (0.76, 2.11) 0.360
 Neutral 0.37 (0.11, 1.19) 0.095 1.05 (0.65, 1.69) 0.833
Prefer to receive XR-NTX (ref=Disagree) F(2, 555)=0.56 0.573
 Agree 1.24 (0.38, 4.06) 0.725 0.72 (0.41, 1.24) 0.231
 Neutral 0.67 (0.23, 1.93) 0.459 0.67 (0.41, 1.10) 0.116
Receiving a preferred medication (ref=No) F(1, 557)=0.03 0.870 0.97 (0.42, 2.26) 0.944 0.90 (0.59, 1.37) 0.613
Cognition
Trails Difference (B-A) F(1, 558)=0.09 0.763 1.01 (0.66, 1.54) 0.976 1.08 (0.89, 1.31) 0.432
Stroop Color-Word raw scorec F(1, 552)=0.05 0.825 1.01 (0.62, 1.64) 0.966 1.07 (0.88, 1.30) 0.484
Stroop Interference raw scorec F(1, 552)=0.07 0.792 1.04 (0.64, 1.71) 0.862 0.97 (0.81, 1.18) 0.780
*

NA indicates that model did not converge due to zero cells

a

Overall effect is a test of the type 3 overall effect of age by baseline measure adjusting for treatment, which tests whether the effect of the baseline measure on the odds of relapse significantly differs between young adults and older adults

b

aOR; adjusting for treatment assignment

c

Analyses using t-scores instead of raw scores for Stroop tests produced similar results